Literature DB >> 23534328

In vivo evaluation of lesion sterilization and tissue repair in primary teeth pulp therapy using two antibiotic drug combinations.

A R Jaya1, P Praveen, A Anantharaj, Karthik Venkataraghavan, Prathibha S Rani.   

Abstract

AIM: The purpose of this study is to evaluate and compare the clinical and radiographic effectiveness of Ciprofloxacin, Minocycline, Metronidazole combination with Ciprofloxacin, Minocycline and Tinidazole combination when used for Lesion Sterilization and Tissue Repair in primary teeth.
METHOD: 25 healthy children, visiting Dept. of Pediatric & Preventive Dentistry, D.A.P.M.R.V. Dental College, Bangalore, India, aged between 6-9 years who were having 30 infected primary teeth are selected and divided into 2 groups. In Group A, a mixture of 3mix-MP Ciprofloxacin, Metronidazole and Minocycline was placed on the floor of the pulp chamber covering the root canal orifices. In Group B a mixture of Ciprofloxacin, Tinidazole and Minocycline was placed as a layer on the floor of the pulp chamber. The procedure was completed in a single visit. Post operative clinical evaluation was done after 1,6,12 and 24 months. Postoperative radiographic evaluation was done at 6, 12 and 24 months.
RESULTS: No statistically significant difference is observed between both the groups and a combination of Ciprofloxacin, Minocycline and Tinidazole antibacterial drugs can be used on teeth pulpally involved with physiologic root resorption.
CONCLUSION: After a 24 Month follow up, we can conclude that primary teeth with the periradicular lesions, can be conserved by using combination of Ciprofloxacin, Minocycline and Tinidazole antibacterial drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23534328     DOI: 10.17796/jcpd.37.2.e5131jp6m1w33v66

Source DB:  PubMed          Journal:  J Clin Pediatr Dent        ISSN: 1053-4628            Impact factor:   1.065


  7 in total

1.  Evaluation of the antimicrobial efficacy of two combinations of drugs on bacteria taken from infected primary teeth (in vitro).

Authors:  R Rafatjou; R Yousefimashouf; M Farhadian; S Afzalsoltani
Journal:  Eur Arch Paediatr Dent       Date:  2019-05-23

2.  In Search of a Novel Substitute: Clinical and Radiological Success of Lesion Sterilization and Tissue Repair with Modified 3Mix-MP Antibiotic Paste and Conventional Pulpectomy for Primary Molars with Pulp Involvement with 18 Months Follow-up.

Authors:  Divya Doneria; Seema Thakur; Parul Singhal; Deepak Chauhan; Karunakar Keshav; Anika Uppal
Journal:  Contemp Clin Dent       Date:  2017 Oct-Dec

3.  Endodontic treatment of chronically infected primary teeth using triple antibiotic paste: An in vivo study.

Authors:  G Anuradha Reddy; E Sridevi; A J Sai Sankar; K Pranitha; M J S Pratap Gowd; C Vinay
Journal:  J Conserv Dent       Date:  2017 Nov-Dec

4.  Clinical and radiographic evaluation of triple antibiotic paste pulp therapy compared to Vitapex pulpectomy in non-vital primary molars.

Authors:  Ohoud T Sijini; Heba J Sabbagh; Khlood K Baghlaf; Amina M Bagher; Azzah A El-Housseiny; Najlaa M Alamoudi; Sara M Bagher
Journal:  Clin Exp Dent Res       Date:  2021-05-31

5.  Comparison of Modified Triple Antibiotic Paste in Two Concentrations for Lesion Sterilization and Tissue Repair in Primary Molars: An In Vivo Interventional Randomized Clinical Trial.

Authors:  Karthika Shankar; Hemalatha Ramkumar; Senthil Dhakshinamoorthy; Shankar Paulindraraj; Trophimus G Jayakaran; Charishma S Bommareddy
Journal:  Int J Clin Pediatr Dent       Date:  2021 May-Jun

6.  Prognostic Factors of Combined Periodontal and Endodontic Lesions: A Retrospective Study.

Authors:  Jinhong Guo; Ying Li; Xuandong Lin; Xiaomei Yang; Wei Shi; Xiaoling Lu
Journal:  Contrast Media Mol Imaging       Date:  2022-08-22       Impact factor: 3.009

Review 7.  Antibiotic Mixtures in Noninstrumental Endodontic Treatment of Primary Teeth with Necrotic Pulps: A Systematic Review.

Authors:  Farah Chouchene; Fatma Masmoudi; Ahlem Baaziz; Fethi Maatouk; Hichem Ghedira
Journal:  Int J Dent       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.